Nutrition state of science and dementia prevention: recommendation of the Nutrition for Dementia Prevention Working Group

The Lancet Healthy Longevity, Volume 3, Issue 7, July 2022, Pages e501-e512
Authors: 
Hussein N Yassine MD a b †, Cécilia Samieri PhD f †, Gill Livingston MD g h, Kimberly Glass PhD i j k, Maude Wagner PhD l q r, Christy Tangney PhD m, Brenda L Plassman PhD s, M Arfan Ikram MD PhD t, Robin M Voigt PhD n o p, Yian Gu MD PhD u, Sid O'Bryant PhD w, Anne Marie Minihane PhD x y, Suzanne Craft PhD z, Howard A Fink MD MPH aa, Suzanne Judd PhD MPH ab, Sandrine Andrieu MD PhD ac ad, Gene L Bowman ND MPH ae af, Edo Richard MD PhD ag ah, Benedict Albensi PhD ai aj ak, Emily Meyers PhD al, Serly Khosravian BA e, Michele Solis PhD al, Maria Carrillo PhD al, Heather Snyder PhD al, Francine Grodstein ScD l †, Nikolaos Scarmeas MD v am †, Prof Lon S Schneider MD MS b c d †

Observational studies suggest that nutritional factors have a potential cognitive benefit. However, systematic reviews of randomised trials of dietary and nutritional supplements have reported largely null effects on cognitive outcomes and have highlighted study inconsistencies and other limitations. In this Personal View, the Nutrition for Dementia Prevention Working Group presents what we consider to be limitations in the existing nutrition clinical trials for dementia prevention. On the basis of this evidence, we propose recommendations for incorporating dietary patterns and the use of genetic, and nutrition assessment tools, biomarkers, and novel clinical trial designs to guide future trial developments. Nutrition-based research has unique challenges that could require testing both more personalised interventions in targeted risk subgroups, identified by nutritional and other biomarkers, and large-scale and pragmatic study designs for more generalisable public health interventions across diverse populations.

Category:

Tags: